Raras
Buscar doenças, sintomas, genes...
Hepatite autoimune
ORPHA:2137CID-10 · K75.4CID-11 · DB96.0PCDT · SUSDOENÇA RARA

É uma inflamação no fígado (hepatite) causada por anticorpos que o próprio corpo produz e que, por engano, atacam o fígado. Remédios, infecções e substâncias tóxicas podem desencadear a produção desses anticorpos que agridem o tecido do fígado.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

É uma inflamação no fígado (hepatite) causada por anticorpos que o próprio corpo produz e que, por engano, atacam o fígado. Remédios, infecções e substâncias tóxicas podem desencadear a produção desses anticorpos que agridem o tecido do fígado.

Pesquisas ativas
25 ensaios
82 total registrados no ClinicalTrials.gov
Publicações científicas
8.284 artigos
Último publicado: 2026 Apr 15

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
1-5 / 10 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Europe
Início
Adolescent
+ adult, childhood, elderly
🏥
SUS: Cobertura mínimaScore: 30%
PCDT disponívelCID-10: K75.4
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🫃
Digestivo
15 sintomas
🫘
Rins
3 sintomas
🧠
Neurológico
2 sintomas
🩸
Sangue
1 sintomas
💪
Músculos
1 sintomas
📏
Crescimento
1 sintomas

+ 33 sintomas em outras categorias

Características mais comuns

100%prev.
Aumento do nível circulante de anticorpos
100%prev.
Aumento do nível circulante de IgG
90%prev.
Roseta
Muito frequente (99-80%)
90%prev.
Positividade do anticorpo anti-antígeno citosólico hepático tipo 1
Muito frequente (99-80%)
90%prev.
Positividade do anticorpo antineutrófilo
Muito frequente (99-80%)
90%prev.
Positividade para anticorpos de músculo liso
Muito frequente (99-80%)
59sintomas
Muito frequente (9)
Frequente (6)
Ocasional (16)
Muito raro (3)
Sem dados (25)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 59 características clínicas mais associadas, ordenadas por frequência.

Aumento do nível circulante de anticorposIncreased circulating antibody level
Muito frequente100%
Aumento do nível circulante de IgGIncreased circulating IgG level
Muito frequente100%
RosetaRosette
Muito frequente (99-80%)90%
Positividade do anticorpo anti-antígeno citosólico hepático tipo 1Anti-liver cytosolic antigen type 1 antibody positivity
Muito frequente (99-80%)90%
Positividade do anticorpo antineutrófiloAntineutrophil antibody positivity
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico8.284PubMed
Últimos 10 anos200publicações
Pico2026125 papers
Linha do tempo
2026Hoje · 2026🧪 1995Primeiro ensaio clínico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 22
1Fase 11
·Pré-clínico17
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 20 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Hepatite autoimune

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

15 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

82 ensaios clínicos encontrados, 25 ativos.

Distribuição por fase
Ver todos no ClinicalTrials.gov
🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
4.309 papers (10 anos)

Mostrando amostra de 200 publicações de um total de 4.309

#1

Anti-MRPS27 Antibody: A Novel Diagnostic Biomarker for Autoimmune Hepatitis Identified via a Human Proteome Microarray.

Hepatology research : the official journal of the Japan Society of Hepatology2026 Mar 23

To identify autoimmune hepatitis (AIH)-specific autoantibodies using a high-content human protein microarray and evaluate their diagnostic performance. Pretreatment sera from untreated patients with AIH (n = 68), primary biliary cholangitis (PBC, n = 19), metabolic dysfunction-associated steatotic liver disease (MASLD, n = 39), chronic hepatitis C (CHC, n = 27), and drug-induced liver injury (DILI, n = 18) and healthy controls (HC, n = 37) were screened with a wheat-germ, cell-free microarray displaying > 16,000 proteins. Candidate antigens were validated by ELISA, and antibody titers were correlated with clinical variables, treatment response, and outcomes. Mitochondrial ribosomal protein S27 (MRPS27) emerged as the dominant AIH-associated antigen. The mean anti-MRPS27 antibody titer in untreated patients with AIH (50.2 AU) exceeded that in patients with PBC (9.3 AU), MASLD (12.8 AU), CHC (24.8 AU), DILI (19.8 AU), and HC (7.5 AU, all p < 0.01). A cutoff of 35.4 AU (HC mean + 2 SD) yielded a sensitivity of 61.8%, a specificity of 87.1%, a positive predictive value of 70.0%, and a negative predictive value of 82.4%. Positivity was unrelated to baseline histology, biochemistry or IgG, and titers were unchanged after corticosteroid induction. Interestingly, patients with low titers experienced more liver-related events during follow-up. The anti-MRPS27 antibody is a promising adjunctive serological marker that enhances the specificity of AIH diagnosis. The pathogenic significance and prognostic value of this antibody warrant prospective validation.

#2

Geographic distribution and demographic patterns of primary biliary cholangitis and autoimmune hepatitis in Colombia: a national population-based administrative study (2018-2024).

Annals of gastroenterology2026

Autoimmune liver diseases, including primary biliary cholangitis (PBC) and autoimmune hepatitis (AIH), are rare chronic conditions with significant morbidity. However, population-based epidemiological data from Latin America remain limited. This study aimed to describe the geographic distribution and demographic patterns of PBC and AIH in Colombia between 2018 and 2024. A descriptive, cross-sectional population-based study was conducted using data from the Comprehensive Social Protection Information System (SISPRO) of the Colombian Ministry of Health. Individuals with at least 1 recorded diagnosis coded as K74.3 (PBC) or K75.4 (AIH) according to the International Classification of Diseases, 10th Revision (ICD-10), were identified. Administrative prevalence estimates were calculated per 100,000 population, using official population projections from the National Administrative Department of Statistics (DANE). Age- and sex-specific distributions were analyzed, and geographic variation was visualized using choropleth maps at the regional level. A total of 6504 PBC cases and 11,225 AIH cases were identified. The estimated national administrative prevalence was 14.7 per 100,000 population for PBC and 17.0 per 100,000 for AIH. Both conditions showed marked female predominance. PBC was more frequent in women aged 50-69 years. However, AIH demonstrated a broader age distribution, affecting individuals from young adulthood to older age. Higher prevalence estimates were observed in multiple northern regions, particularly in the Caribbean region. This first nationwide administrative assessment of PBC and AIH in Colombia demonstrates marked sex differences and regional variation, highlighting the need to improve diagnostic awareness and strengthen epidemiological surveillance of autoimmune liver diseases in Latin America.

#3

Integrative omics and phase IIa clinical trial identify TNF as key node in autoimmune hepatitis.

Journal of hepatology2026 Mar 19

Autoimmune hepatitis (AIH) patients experience increased mortality and severe side effects from non-specific immunosuppressive therapy, highlighting an urgent need for targeted treatment approaches. Here, we aimed to delineate the cellular and molecular network underlying AIH within its spatial context and to validate a key therapeutic target in a clinical trial. We employed computational modelling, multi-omics analyses, and functional experiments to map the immune landscape of AIH. In addition, we conducted a steroid-free open-label phase IIa clinical trial using infliximab, a TNF-targeting antibody, in AIH patients. Our studies revealed that myeloid cell and hepatocyte-derived IL-15 promotes cytotoxicity and proliferation of liver auto-aggressive CD8+ T cells. Full execution of their cytotoxic program is licensed by TNF derived from clonally expanded liver-resident CD4+ T cells. AIH hepatocytes respond to TNF by increasing expression of adhesion molecules making them targets for both CD8+ and CD4+ T cells. In the clinical trial, targeting TNF with infliximab demonstrated efficacy as an entirely steroid-free AIH treatment. These findings elucidate the immune network in AIH and identify TNF as one of the central network nodes. Accordingly, our findings provide the basis for novel targeted, steroid-free immune therapies such as the use of infliximab. These findings have significant implications for the treatment of autoimmune hepatitis. By mapping the spatial and functional immune network within the AIH liver, this study identifies IL-15 and TNF as central drivers of T cell-mediated cytotoxicity, offering new precision targets for intervention. The successful use of infliximab as a steroid-free therapy in a phase II trial marks a pivotal step toward safer, more specific treatment options for AIH patients. This research not only advances our understanding of AIH pathogenesis, but also sets the stage for broader application of immune-targeted therapies in autoimmune liver diseases.

#4

Association between serum uric acid and non-alcoholic fatty liver disease (NAFLD): an observational cross-sectional study in an Egyptian outpatient cohort.

BMC gastroenterology2026 Mar 19

Hepatic steatosis, characterized by excessive triglyceride accumulation within hepatocytes, is the central feature of non-alcoholic fatty liver disease (NAFLD). This spectrum encompasses simple steatosis, non-alcoholic steatohepatitis (NASH), progressive fibrosis, and cirrhosis. NAFLD pathogenesis involves an intricate interplay between nutritional factors, metabolic dysregulation, and genetic predisposition. Evidence suggests hyperuricemia is an independent risk factor for NAFLD, with elevated serum uric acid (SUA) levels associated with increased steatosis severity and fibrosis advancement. This study investigated the association between SUA levels and liver involvement—specifically ultrasound-assessed steatosis grading and elastography-measured liver stiffness—in patients with NAFLD. This cross-sectional study enrolled 70 patients aged ≥18 years with ultrasound-diagnosed NAFLD (Group I) and 70 age-, sex-, and residence-matched healthy controls (Group II). Participants were recruited from Minia University Liver Hospital between March 2022 and February 2023. Exclusion criteria included excessive alcohol consumption, viral or autoimmune hepatitis, established cirrhosis, and medications affecting uric acid metabolism. The primary outcome was presence of NAFLD. Evaluations comprised detailed medical history, anthropometric measurements, laboratory testing (including SUA), abdominal ultrasonography for steatosis grading, and two-dimensional shear wave elastography for liver stiffness assessment. Hyperuricemia prevalence reached 55.7% (n=39) among NAFLD patients compared to 0% in controls (p=0.001). Mean SUA concentrations were significantly elevated in the NAFLD group versus controls (5.98 ± 1.9 mg/dL vs. 4.34 ± 0.7 mg/dL, p=0.001). A significant association emerged between hyperuricemia and hepatic steatosis grades (p=0.032). Multivariate logistic regression identified SUA as independently associated with NAFLD after adjustment for confounders (Adjusted OR 1.45; 95% CI: 1.12–1.88, p=0.005 per 1 mg/dL increment), alongside BMI, waist circumference, triglycerides, and creatinine. Receiver operating characteristic (ROC) analysis demonstrated an optimal 5.3 mg/dL SUA cut-off for NAFLD discrimination (AUC 0.74, 64% sensitivity, 94% specificity, p=0.001). Elevated SUA levels were consistently associated with NAFLD presence, steatosis severity, and increased liver stiffness. The 5.3 mg/dL threshold warrants further validation. Notable limitations include single-center recruitment potentially limiting generalizability, a cross-sectional design precluding temporal relationship and causality determination, and the possibility of residual confounding from unmeasured variables. The online version contains supplementary material available at 10.1186/s12876-026-04655-2.

#5

Autoimmune Hepatitis Unmasked by Acute Viral Hepatitis: A Diagnostic and Therapeutic Challenge.

Journal of clinical and experimental hepatology2026

Autoimmune hepatitis (AIH) is a rare disease with unclear pathogenesis. Acute viral hepatitis (AVH) can trigger autoimmunity and unmask underlying AIH, which can be difficult to recognize due to overlapping clinical features. This case series included 10 patients diagnosed with AIH following confirmed AVH. Demographics, clinical presentation, investigations, biopsy results, and treatment outcomes were analyzed. Diagnosis of AIH was established using the simplified AIH score. The cohort included seven patients with hepatitis A virus, two with hepatitis E virus, and one with hepatitis B virus. Mean age was 26.9 ± 10.6 years with male predominance (n = 7,70%). Median time to AIH diagnosis was 82 (68-125) days after initial symptoms. Serum immunoglobulin G was elevated in all patients [median: 1834.5(1138-3858 mg/dL); normal <1700 mg/dL]. Anti-nuclear antibody was positive in 40%, anti-smooth muscle antibody in 30%, with 40% being seronegative. Liver biopsies showed interface hepatitis (90%), lobular inflammation (100%), and lymphoplasmacytic infiltrate (100%). Fibrosis (Metavir scoring system) stages were F0 (30%), F1 (20%), F2 (30%), and F3 (20%). All patients achieved complete biochemical remission with prednisolone (dose: 0.5-1 mg/kg/day, and azathioprine (dose: 1-2 mg/kg/day, median initiation time: 45 days after prednisolone start). One attempt at immunosuppression withdrawal resulted in flare. AVH can unmask underlying AIH and protracted course beyond the expected course of AVH for prompt evaluation of AIH. Standard immunosuppressive therapy is generally effective and long-term maintenance treatment may be required.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC4.581 artigos no totalmostrando 193

2026

Cholestatic liver disease in an adolescent: don't forget progressive familial intrahepatic Cholestasis-8.

Oxford medical case reports
2026

Research progress on the role of gut microbiota dysbiosis in the pathogenesis of immune-mediated liver diseases.

Frontiers in immunology
2026

Anti-MRPS27 Antibody: A Novel Diagnostic Biomarker for Autoimmune Hepatitis Identified via a Human Proteome Microarray.

Hepatology research : the official journal of the Japan Society of Hepatology
2026

Meta-Analysis: PPAR Agonists for Pruritus and Quality of Life in Primary Biliary Cholangitis.

Alimentary pharmacology &amp; therapeutics
2026

Geographic distribution and demographic patterns of primary biliary cholangitis and autoimmune hepatitis in Colombia: a national population-based administrative study (2018-2024).

Annals of gastroenterology
2026

Integrative omics and phase IIa clinical trial identify TNF as key node in autoimmune hepatitis.

Journal of hepatology
2026

Fostamatinib Dual Immunomodulation in Post-Haploidentical HSCT Autoimmune Cytopenia and Autoimmune Hepatitis: A Case Report and Review of Literature.

Journal of clinical immunology
2026

Association between serum uric acid and non-alcoholic fatty liver disease (NAFLD): an observational cross-sectional study in an Egyptian outpatient cohort.

BMC gastroenterology
2026

Autoimmune Hepatitis Unmasked by Acute Viral Hepatitis: A Diagnostic and Therapeutic Challenge.

Journal of clinical and experimental hepatology
2026

Naringin alleviates autoimmune hepatitis in mice via the gut-liver Axis through modulation of microbiota, metabolites, and immune responses.

International immunopharmacology
2026

Dual Positivity for AMA/AMA-M2 and Anti-gp210/sp100 Shows Highest Diagnostic Value for Primary Biliary Cholangitis.

Alimentary pharmacology &amp; therapeutics
2026

Transient elastography for accurate staging of liver fibrosis and predicting complications in children with autoimmune hepatitis.

Journal of pediatric gastroenterology and nutrition
2026

Late-onset combined immunodeficiency and bone marrow failure in severe autoimmune hepatitis: a case report.

Journal of medical case reports
2026

In vivo CAR-Tfh cell reprogramming restores tolerance in a mouse model of autoimmune hepatitis.

Cell stem cell
2026

Anti-Inflammatory Effects of Goat Whey Protein in Concanavalin-A Induced Hepatitis.

Nutrients
2026

Mast Cells at the Crossroad of Gut-Derived Signals Through Aryl Hydrocarbon Receptor Activation: A Microbial-Immune Dialogue in Liver Inflammation with Therapeutic Perspectives.

Cells
2026

Autoimmune Hepatitis: A Review of Molecular Mechanisms and Research Gaps in African Populations.

Biology
2026

Autoimmune Hepatitis and Pregnancy: A Case Report.

The Journal of the Association of Physicians of India
2026

Constructing a protein-protein interaction network for autoimmune liver diseases by integrating pQTL, rQTL, and mediation analyses.

Naunyn-Schmiedeberg's archives of pharmacology
2026

[Infliximab-induced autoimmune-like hepatitis developed during treatment for Crohn's disease:a case report].

Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology
2026

Assessing the associations between immunosuppressant use and COVID-19 severity in patients with autoimmune hepatitis.

World journal of hepatology
2026

Characterization of CD24+ T Cells and Their Cytokine Signature in Autoimmune Hepatitis.

Journal of clinical and experimental hepatology
2026

Tumor Necrosis Factor-Alpha (TNF-α) Inhibitor Treatment in Hidradenitis Suppurativa: A Population-Based Retrospective Cohort Study of Comorbid Risks.

Cureus
2026

An imbalance between CD80 and CD86 levels and CD4 regulatory T cell number and transendocytosis function exists in the liver in autoimmune hepatitis.

Clinical and experimental immunology
2026

Drug-induced autoimmune hepatitis due to atorvastatin: a complex clinical case and literature review.

Gastroenterology report
2026

Elevated Polyreactive Immunoglobulin G in Immune-Mediated Liver Injuries With the Need for Immunosuppressive Therapy.

Liver international : official journal of the International Association for the Study of the Liver
2026

Can liver biopsy be spared for the diagnosis of autoimmune hepatitis in selected children? A multicenter retrospective study.

Annals of hepatology
2026

Predicting VRE Infection After Liver Transplantation With a Time-Updated Colonization Score.

Transplant infectious disease : an official journal of the Transplantation Society
2026

Prevalence, clinical features, and laboratory predictors of autoimmune hepatitis in systemic sclerosis: A retrospective single-center cohort study.

Clinical rheumatology
2026

Ubiquitin-Conjugating Enzyme E2O Primes Hepatocytes to Restore Immune Tolerance in Autoimmune Hepatitis via Inhibiting Y-Box Binding Protein 1/Interleukin-6 Axis.

Cellular and molecular gastroenterology and hepatology
2026

Indian National Association for Study of the Liver Guidance Document on Difficult to Treat Autoimmune Hepatitis.

Journal of clinical and experimental hepatology
2026

Immune profiling links autoimmune hepatitis to human herpesvirus 6 and relaxin receptor antigens.

The Journal of experimental medicine
2026

Nlrp12-driven PANoptosis exacerbates liver injury in ConA-induced autoimmune hepatitis.

Genes and immunity
2026

Sjögren Syndrome Associated Limbic Encephalitis and Its Longitudinal Brain FDG PET Manifestations.

Clinical nuclear medicine
2026

Acquired bisalbuminemia associated with hepatobiliary disease: a two-case report and diagnostic implications.

Laboratory medicine
2026

Proctocolectomy with permanent ileostomy is associated with improved transplant-free survival in patients with PSC.

JHEP reports : innovation in hepatology
2026

Dosing and Route of Steroid Induction Therapy in Non-Severe Autoimmune Hepatitis Do Not Affect Time to Biochemical Response.

JGH open : an open access journal of gastroenterology and hepatology
2026

Unmasking Parasitic Colitis Mimicking Inflammatory Bowel Disease.

Cureus
2026

Genotype-Phenotype Delineation of Autoimmune Polyendocrinopathy, Candidiasis, and Ectodermal Dystrophy in a Pediatric Patient: A Case Report.

Genes
2026

How do oral pathogenic bacteria potentially contribute to inflammatory processes in autoimmune liver disease? Results from a systematic review.

Clinics and research in hepatology and gastroenterology
2026

Network pharmacological and experimental validation of the mechanism of Chaihu Guizhi Ganjiang decoction regulating T helper cell 17/regulatory T cell balance to improve autoimmune hepatitis.

Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan
2026

Azathioprine-Associated Acute Pancreatitis Followed by a Probable Autoimmune Hepatitis Flare After Thiopurine Withdrawal: A Case Report.

Cureus
2026

Isolated IgG elevation in patients with persistently normal transaminases does not affect the outcome of autoimmune hepatitis: or just a little bit?

JHEP reports : innovation in hepatology
2026

Regulatory T-cells in autoimmune hepatitis: An historical perspective with hints to the future.

JHEP reports : innovation in hepatology
2026

Deciphering the potential molecular mechanism of resmetirom in idiosyncratic drug- induced autoimmune hepatitis using network toxicology and molecular docking.

In silico pharmacology
2026

CX3CL1/CX3CR1 axis in liver disease: context-dependent roles and balance.

Frontiers in immunology
2026

Hepatic Manifestations of STAT1 Gain-of-Function Variants.

The journal of allergy and clinical immunology. In practice
2026

Clinical Characteristics of Chronic Pancreatitis in a Saudi Arabian Population: A Retrospective Cohort Study at Riyadh Second Health Cluster.

Journal of epidemiology and global health
2025

Kikuchi Disease Unveiling Systemic Lupus Erythematosus: A Rare Case of Initial Manifestation.

Oman medical journal
2026

Human leukocyte antigen variants and clinical features of primary biliary cholangitis: Cumulative contributions.

World journal of clinical cases
2026

Letter on 'Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune Hepatitis': Authors' Reply.

Alimentary pharmacology &amp; therapeutics
2026

Azathioprine-induced acute generalized exanthematous pustulosis in a woman with autoimmune hepatitis.

Dermatology reports
2026

A rare case of pediatric autoimmune pancreatitis and autoimmune hepatitis in a patient with sickle cell disease.

JPGN reports
2026

A case of autoimmune hepatitis in a patient with inflammatory bowel disease and significant lymphadenopathy in the porta hepatis.

JPGN reports
2026

Case Report: IL2RA (CD25) deficiency: first reported cases in Morocco.

Frontiers in immunology
2025

NON-INVASIVE QUANTITATIVE CT PERFUSION OF THE LIVER IN AUTOIMMUNE HEPATITIS.

Georgian medical news
2026

Liver Disease in Common Variable Immunodeficiency: Current Evidence and Knowledge Gaps.

International journal of molecular sciences
2026

Primary Biliary Cholangitis Pathogenesis: A Pathophysiology-Based Narrative Review.

International journal of molecular sciences
2026

Antinuclear antibody targets in autoimmune hepatitis and drug-induced liver injury: Diagnostic relevance of nucleosome antibodies.

Journal of translational autoimmunity
2026

Pulmonary aspergillosis diagnosed during surgical treatment for spontaneous pneumothorax: a case report.

AME case reports
2026

Primary sclerosing cholangitis in children: a single-center experience and evaluation of prognostic markers.

Translational gastroenterology and hepatology
2026

The Geoepidemiology of Autoimmune Hepatitis.

Clinical reviews in allergy &amp; immunology
2025

Evaluation of Histological Criteria and Immunoserological Testing of Simplified Criteria for the Diagnosis of Autoimmune Hepatitis.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
2026

Extrahepatic Autoimmune Diseases in Autoimmune Hepatitis: Their Prevalence, Predictors, and Influence on Early Treatment Outcomes.

Journal of clinical and translational hepatology
2026

Association between type 2 diabetes and autoimmune liver disease: An integrated analysis of Mendelian randomization and clinical samples.

Medicine
2026

Association between osteoporosis and waitlist mortality in liver transplant candidates.

Scientific reports
2026

Not always autoimmune hepatitis: Hepatic steatosis is associated with autoantibodies positivity in patients with hepatocellular dysfunction.

World journal of hepatology
2026

Strengthening the stratification of autoimmune hepatitis: toward enhanced clinical applicability.

Hepatology international
2026

Autoimmune hepatitis overlap syndrome: Clinical presentation, treatment response, and disease evolution: Tertiary centre experience.

Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
2026

Clinical and Demographic Profile of Wilson Disease in Young Adults: A Retrospective Study at a Tertiary Care Center in Peshawar, Pakistan.

Cureus
2026

A Mysterious Case of Autoimmune Hepatitis Triggered by Herpes Zoster Virus Versus Drug-Induced Liver Injury.

Cureus
2026

Screening and identification of a novel PGAM5-specific inhibitor for attenuating multi-organ injury.

Journal of advanced research
2026

[A case of toxic shock syndrome secondary to severe bone marrow suppression induced by azathioprine in a patient with autoimmune hepatitis].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
2026

Refining the definition of acute autoimmune hepatitis: implications for classification and prognosis.

Hepatology international
2025

An Association Between Autoimmune Hepatitis (AIH) and Immunoglobulin G4-Related Disease (IgG4-RD) in a Male Diagnosed With Primary Sjögren's Syndrome (SJS): A Case-Based Review.

Cureus
2026

Complementary use of autoantibody detection methods facilitates diagnosis of juvenile autoimmune hepatitis and autoimmune sclerosing cholangitis.

JHEP reports : innovation in hepatology
2026

Extending the Baveno VII definition of recompensation to autoimmune hepatitis: Considerations regarding treatment timing and response criteria.

JHEP reports : innovation in hepatology
2026

Quality of Life in Patients With Variant Syndromes of Autoimmune Liver Diseases-A Cross-Sectional Multicentre Study.

Liver international : official journal of the International Association for the Study of the Liver
2026

Simvastatin Alleviates ConA-Induced Autoimmune Hepatitis by Inhibiting CD4+ T Cell Activation via Calcium-NFATC3 Pathway.

Inflammation
2026

Clinical course and prognostic risk factors of SARS-CoV-2 vaccine-related hepatitis: differentiating severe acute respiratory syndrome coronavirus 2 vaccine-associated liver injury from autoimmune hepatitis.

European journal of gastroenterology &amp; hepatology
2026

Cleavage-Resistant CYLD Protects Against Autoimmune Hepatitis.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
2025

Clinical characteristics and outcomes in 50 children with autoimmune hepatitis: a retrospective study from a single centre in China.

Frontiers in medicine
2026

6-Mercaptopurine vs Mycophenolate Mofetil in Autoimmune Hepatitis and Azathioprine Intolerance: A Multicenter Study.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
2026

Association between thyroid diseases and autoimmune hepatitis: A bidirectional Mendelian randomization study.

Medicine
2026

COLEC10 and COLEC11 are new serum biomarkers of chronic liver disease.

European journal of medical research
2026

Organ-specific autoimmunity in primary Sjögren's disease.

Scandinavian journal of rheumatology
2026

Shaping the Profile of Liver Transplantation for Autoimmune Hepatitis in North and Northeastern Brazil.

Transplantation
2025

Autoimmune Hepatitis Presenting With Severe Pruritus in a 27-Year-Old Male.

Cureus
2026

The Great Imitator: Syphilitic Hepatitis Presenting as a Mimic to Autoimmune Liver Disease.

Military medicine
2026

Sensitivity and specificity of magnetic resonance elastography in liver diseases in the pediatric age group.

Clinics and research in hepatology and gastroenterology
2026

Massive hepatic necrosis-associated acute liver failure.

eGastroenterology
2026

Immunoglobulin G4-related disease with multi-organ involvement: A case report.

Medicine
2025

Efavirenz-Induced Hepatitis Mimicking Autoimmune Hepatitis: A Case Report.

Cureus
2026

Inhibition of estrogen receptor alpha stabilizes regulatory T cell function in autoimmune hepatitis.

JHEP reports : innovation in hepatology
2026

Liver Biopsy Features May Help Distinguish Drug-Induced Autoimmune-Like Hepatitis From Idiopathic Autoimmune Hepatitis.

Archives of pathology &amp; laboratory medicine
2026

DPMAS in the Management of Severe Acute Liver Injury.

Case reports in hepatology
2026

Autoimmune Hepatitis and Depression.

The American journal of gastroenterology
2026

Annexin A5 ameliorates immune-mediated liver injury by regulating ferritinophagy-ferroptosis in M2 macrophages via the NRF2/ERK pathway.

Cellular signalling
2026

Severe autoimmune hepatitis and necrotising pancreatitis following ofatumumab in a patient with multiple sclerosis.

BMJ case reports
2025

Dysgeusia-Driven Nutritional Decline in Cirrhosis: A Case of Autoimmune Hepatitis and Primary Biliary Cholangitis.

Cureus
2026

Inferior Vena Cava-Atrial Anastomosis in Liver Transplant Recipient with Inferior Vena Cava Occlusion: A Case Report and Literature Review.

Journal of clinical medicine
2025

Increased Intrahepatic Mast Cell Density in Liver Cirrhosis Due to MASLD and Other Non-Infectious Chronic Liver Diseases.

International journal of molecular sciences
2025

MAIT Cells in Liver Disease.

Cells
2026

Intrahepatic Lymphedema Presenting With Abnormal Bilirubin Metabolism as the Initial Manifestation.

ACG case reports journal
2026

[A case of recurrent hypoglycemic coma episodes associated with primary biliary cholangitis and literature review].

Zhonghua nei ke za zhi
2026

Depression Aggravates Immune-Mediated Hepatitis Through NLRP3 Overactivation Induced by Intestinal Microbiota.

CNS neuroscience &amp; therapeutics
2026

Retrospective, single-center analysis of autoimmune hepatitis in Yemeni adults: clinical features, treatment, and outcomes.

BMC immunology
2026

Elevated neutrophil-to-lymphocyte ratio and the incidence of autoimmune diseases: evidence from a large prospective cohort study.

Scientific reports
2026

Management of autoimmune hepatitis-related decompensated cirrhosis: current evidence and clinical decision-making.

Current opinion in gastroenterology
2026

IgG4-Associated Autoimmune Hepatitis: a Systematic Review.

Journal of gastroenterology and hepatology
2026

Discovery of Novel Nonsteroidal SGRMs of Sulfonamide-2-Oxo-Tetrahydroquinoline Derivatives by Carbonyl Migration.

Journal of medicinal chemistry
2026

Genuine acute autoimmune hepatitis has better therapeutic response and prognosis.

Hepatology international
2026

Management of Severe Abemaciclib-induced Liver Dysfunction: Feasibility of Switching to Palbociclib.

In vivo (Athens, Greece)
2025

Gluten's silent strike: Unmasking its impact on liver health.

World journal of gastrointestinal pathophysiology
2025

Drug-induced liver injury in inflammatory bowel disease: Challenges in diagnosis and monitoring.

World journal of hepatology
2025

Refractory autoimmune hepatitis in children: Considerations for assessment and management.

World journal of hepatology
2025

Impact of age on autoimmune hepatitis: A comparative study of patients diagnosed before and after sixty.

World journal of hepatology
2025

Cell-specific epigenome-wide DNA methylation in peripheral CD4(+) lymphocytes from patients with primary biliary cholangitis.

Journal of translational autoimmunity
2025

Autoimmune Hepatitis After Successful Treatment of Chronic Hepatitis C Virus Infection with Direct-Acting Antivirals: A Pediatric Case Report.

Pathogens (Basel, Switzerland)
2025

Rare Lupus Exacerbation Shines Light on Provider Bias in a Patient With Possible Autoimmune Hepatitis.

Cureus
2025

Wilson's Disease with Autoimmune Hepatitis Manifestation in a Pediatric Patient: A Case Report and Literature Review.

Journal of clinical medicine
2025

Liver Innervation in Health and Disease: Neuroimmune-Neurovascular Interface and Future Therapeutic Implications.

Biomedicines
2025

Clinical characteristics and factors associated with liver stiffness in patients with autoimmune liver disease: a cross-sectional study from the Kashgar region.

BMC gastroenterology
2025

Graves' disease with autoimmune hepatitis and primary Sclerosing cholangitis: an overlap syndrome.

Oxford medical case reports
2025

Acute hepatitis secondary to Mycoplasma pneumoniae infection.

Boletin medico del Hospital Infantil de Mexico
2025

Pediatric autoimmune hepatitis in the Asia-Pacific region: practical considerations for guideline implementation.

Hepatology international
2025

Severe Hepatitis in a Patient With Undifferentiated Connective Tissue Disease: Diagnostic Uncertainty Between Methotrexate Toxicity and Autoimmune Liver Involvement.

Cureus
2025

Hepatocyte guardian: A20 restrains ferroptosis in autoimmune hepatitis.

Gut
2026

Acute Severe Autoimmune Hepatitis With Superimposed Scrub Typhus: An Uncommon Cause of Subacute Hepatic Failure Identified in Autopsy.

Journal of clinical and experimental hepatology
2026

PBC-AIH variant syndrome: emerging new terminology and a new approach to diagnosis and management.

Current opinion in gastroenterology
2025

Bone marrow-derived CD169+ macrophages promote autoimmune hepatitis by recruiting CCR2+ monocytes via secreting CCL12.

Experimental &amp; molecular medicine
2026

A Novel BAFF/APRIL Dual Inhibitor in Treating Refractory Autoimmune Hepatitis.

Liver international : official journal of the International Association for the Study of the Liver
2026

The pediatric medical liver biopsy: indications, procedures, and histopathology.

Expert review of gastroenterology &amp; hepatology
2026

Autoimmune Hepatitis: Histopathological Diversity and Its Clinical Implications.

Hepatology research : the official journal of the Japan Society of Hepatology
2026

Prevalence and risk factors of portopulmonary hypertension in chronic liver disease: systematic review and meta-analysis.

Clinics and research in hepatology and gastroenterology
2025

Left-Sided Diaphragmatic Hernia Following Pediatric Liver Transplantation: First Reported Case From the Middle East.

Cureus
2025

RIPK1 inhibition reduces biliary injury and fibrosis in primary sclerosing cholangitis.

Science advances
2026

Global epidemiology and determinants of autoimmune hepatitis recurrence post- liver transplantation: A systematic review and meta-analysis.

Transplantation reviews (Orlando, Fla.)
2025

Pediatric consensus of autoimmune hepatitis.

Boletin medico del Hospital Infantil de Mexico
2026

Autoimmune Features in Sickle Cell Patients: A New Explanation for Liver Damage?

American journal of hematology
2025

Conversion from veno-arterial to veno-pulmonary ECMO for refractory pulmonary hypertension and right ventricular failure after orthotopic liver transplantation.

BMJ case reports
2025

Idiosyncratic Warfarin-Induced Hepatocellular Injury: A Reversible and Uncommon Occurrence.

Cureus
2025

Challenges in the Diagnosis of Autoimmune Hepatitis in Patients With Chronic Viral Hepatitis C: A Case Series and Review of the Literature.

Cureus
2026

Autoimmune liver diseases in Latin America: Current landscape and challenges.

Hepatology communications
2025

Pruritus and health-related quality of life in chronic liver disease: a longitudinal, survey-based cohort study.

BMJ open gastroenterology
2025

The detrimental effect of autoimmune hepatitis in pregnancy: a systematic review and meta-analysis.

Annals of medicine and surgery (2012)
2025

From Isolation to Information: Launching an Online Community for Patients with Primary Sclerosing Cholangitis, Primary Biliary Cholangitis, and Autoimmune Hepatitis in Romania-A Descriptive Study.

Healthcare (Basel, Switzerland)
2025

Beyond bones: Revisiting the role of vitamin D in chronic liver disease.

World journal of hepatology
2025

Autoimmune-like hepatitis induced by drugs: Still many unanswered questions.

World journal of hepatology
2025

Unveiling the Spectrum of Liver Endurance in Systemic Lupus Erythematosus: A Single-Center Experience From Kashmir, India.

Cureus
2026

Expanded but dysfunctional regulatory T cells in treatment-naïve autoimmune hepatitis.

Hepatology international
2026

Discrepancy between international guidelines and global laboratory practices in autoantibody testing for autoimmune hepatitis.

Autoimmunity reviews
2025

Risk factors for autoimmune liver disease recurrence after liver transplantation.

World journal of transplantation
2025

Triple autoimmune overlap syndrome of the liver: a rare case of concomitant PBC, PSC, and AIH.

Future science OA
2025

Genome-annotated bivariate analysis of shared heritability in autoimmune hepatitis with psychiatric comorbidity.

Scientific reports
2026

Autoantibodies neutralizing type I IFNs in patients with fulminant herpes simplex virus hepatitis.

The Journal of experimental medicine
2025

Decoding the distinct immune landscape and possible regulatory mechanisms of autoimmune hepatitis through integrated single-cell and bulk RNA sequencing.

PloS one
2025

Human umbilical cord-derived mesenchymal stem cells alleviate autoimmune hepatitis by inhibiting hepatic ferroptosis.

PloS one
2025

Coagulation abnormalities in children with chronic liver disease and the association of these abnormalities with disease severity.

iLIVER
2025

Alfuzosin-Induced Autoimmune Hepatitis: A Rare Case Report.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
2025

Latent TB treatment outcomes in patients with chronic liver disease: A retrospective cohort study.

Journal of clinical tuberculosis and other mycobacterial diseases
2025

Association between ABO blood group system and autoimmune liver disease.

Frontiers in medicine
2025

The pivotal role of cytokines in liver disease pathogenesis and therapeutic potential.

Frontiers in immunology
2025

Unraveling the Complexity: A Case of Systemic Lupus Erythematosus, Warm Autoimmune Hemolytic Anemia, and Autoimmune Cholangitis.

Cureus
2026

Autoimmune liver diseases in the Asia Pacific region: proceedings of the autoimmune liver disease course at APASL 2025.

Hepatology international
2026

Neutrophil-T cell cross talk in noninfectious liver diseases.

American journal of physiology. Gastrointestinal and liver physiology
2025

From thrombosis to transplantation: The role of anti-phospholipid antibodies in liver disease management.

iLIVER
2025

AMA-Negative Primary Biliary Cholangitis and Autoimmune Hepatitis Overlap Syndrome Presenting With Bullous Pemphigoid: A Case Report.

Clinical case reports
2026

Autoimmune Hepatitis Profiles After Liver Transplantation in Latin American Patients: A Cluster Analysis of Clinical Outcomes.

Hepatology research : the official journal of the Japan Society of Hepatology
2025

Beyond biochemical remission: roadmap for integrating health-related quality of life into autoimmune hepatitis management and research.

Hepatology international
2025

An association between antibiotic usage during pregnancy and the subsequent development of autoimmune hepatitis.

Canadian liver journal
2025

Hypereosinophilic syndrome with pulmonary and hepatic involvement mimicking autoimmune disease.

Oxford medical case reports
2025

DNAzyme targeting RIP3 suppresses NLRP3-mediated necroinflammation for the treatment of inflammatory diseases.

Acta pharmaceutica Sinica. B
2025

Immunoglobulin G4-related Autoimmune Hepatitis: Diagnosis and Treatment.

Journal of clinical and translational hepatology
2025

Clinical and pathological features of antinuclear antibody-positive drug-induced liver injury compared with autoimmune hepatitis: A retrospective study.

Medicine
2025

Gut microbiota-derived metabolites modulate Treg/Th17 balance: novel therapeutic targets in autoimmune diseases.

Frontiers in immunology
2025

Management of refractory autoimmune hepatitis with rituximab: a case series.

Journal of medical case reports
2026

Peiminine modulates T cell-associated gene expression and inflammatory activity in experimental autoimmune hepatitis.

Cellular immunology
2026

Letter on 'Clinical Features of Portal Hypertension and Their Prognostic Implications in Patients With Autoimmune Hepatitis'.

Alimentary pharmacology &amp; therapeutics
2025

Pulse Granuloma-Like Lesion of the Portal Vein in a Liver Explant: A Case Supporting the Endogenous Theory.

Cureus
2025

Long-term outcome of bone marrow transplantation in NIK deficiency: non-redundant role of non-canonical NF-κB signaling in thymic reconstitution and secondary lymphoid organ development.

Frontiers in immunology
2025

Diagnostic Utility of Liver Biopsy in Persistent Unexplained Liver Enzyme Elevation: A Retrospective Cohort Study.

JGH open : an open access journal of gastroenterology and hepatology
2025

ABCB4 disease-causing variants S242R, S346I, T437I and T1077M significantly impair its function and display differential sensitivity to potentiators.

Scientific reports
2025

Chronic drug-induced liver injury in a child with acute lymphoblastic leukemia: a case report.

BMC pediatrics
2025

Systemic PCSK9 elevation characterises autoimmune liver disease across sexes.

Scientific reports
2025

An overview of paediatric autoimmune and genetic cholestatic liver disease for the adult physician.

Clinical medicine (London, England)
2025

Autoimmune hepatitis in children: Guidelines of the Indian Society of Pediatric Gastroenterology, Hepatology, and Nutrition (ISPGHAN).

Hepatology international
2025

Metabolomics in autoimmune hepatitis: progress and perspectives.

Frontiers in medicine
2025

The risk of psychiatric disorders in patients with autoimmune hepatitis: a nationwide registry-based follow-up study.

The American journal of gastroenterology
2025

The risk and prevalence of hepatic diseases in psoriasis: A systematic review and meta-analysis.

Journal of the European Academy of Dermatology and Venereology : JEADV
2026

Simultaneous degenerative changes in 2 hepatic cavernous hemangiomas observed over 23 years of follow-up: A case report and review of the literature.

Radiology case reports
2025

Digestive autoimmune diseases mimicking gastrointestinal manifestations in children with sickle cell anemia: A report of three cases.

JPGN reports
2025

Hepatobiliary Adverse Events Linked to Immune Checkpoint Inhibitors: A Real-World Pharmacovigilance Analysis Using FAERS Data.

Thoracic cancer
Ver todos os 4.581 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Hepatite autoimune.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Hepatite autoimune

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Anti-MRPS27 Antibody: A Novel Diagnostic Biomarker for Autoimmune Hepatitis Identified via a Human Proteome Microarray.
    Hepatology research : the official journal of the Japan Society of Hepatology· 2026· PMID 41871135mais citado
  2. Geographic distribution and demographic patterns of primary biliary cholangitis and autoimmune hepatitis in Colombia: a national population-based administrative study (2018-2024).
    Annals of gastroenterology· 2026· PMID 41868883mais citado
  3. Integrative omics and phase IIa clinical trial identify TNF as key node in autoimmune hepatitis.
    Journal of hepatology· 2026· PMID 41864242mais citado
  4. Association between serum uric acid and non-alcoholic fatty liver disease (NAFLD): an observational cross-sectional study in an Egyptian outpatient cohort.
    BMC gastroenterology· 2026· PMID 41857494mais citado
  5. Autoimmune Hepatitis Unmasked by Acute Viral Hepatitis: A Diagnostic and Therapeutic Challenge.
    Journal of clinical and experimental hepatology· 2026· PMID 41852657mais citado
  6. When to Consider AIH-PBC OverlapSyndrome in the Pathology Report.
    Am J Surg Pathol· 2026· PMID 41989769recente
  7. [A non-invasive diagnostic evaluation study on liver fibrosis in children with autoimmune hepatitis].
    Zhonghua Er Ke Za Zhi· 2026· PMID 41986266recente
  8. Specific Therapies For ALF: Viral, Autoimmune and Wilson Disease.
    J Intensive Care Med· 2026· PMID 41984025recente
  9. The role of Traditional Chinese Medicine in the management of liver disease: targeting gut microbiome.
    Chin Med· 2026· PMID 41981689recente
  10. Use of Machine Learning in Predicting the Risk of Cirrhosis in Autoimmune Hepatitis Based on Clinical and Immunological Indicators.
    Diagnostics (Basel)· 2026· PMID 41975687recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:2137(Orphanet)
  2. MONDO:0016264(MONDO)
  3. Hepatite Autoimune(PCDT · Ministério da Saúde)
  4. GARD:5871(GARD (NIH))
  5. Busca completa no PubMed(PubMed)
  6. Artigo Wikipedia(Wikipedia)
  7. Q786844(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Hepatite autoimune
Compêndio · Raras BR

Hepatite autoimune

ORPHA:2137 · MONDO:0016264
🇧🇷 Brasil SUS
Geral
Prevalência
1-5 / 10 000
Herança
Not applicable
CID-10
K75.4 · Hepatite autoimune
CID-11
Ensaios
25 ativos
Início
Adolescent, Adult, Childhood, Elderly
Prevalência
0.0 (Europe)
MedGen
UMLS
C0241910
EuropePMC
Wikidata
Wikipedia
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades